Compare MYSZ & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | SCNI |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | Israel | Israel |
| Employees | 45 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.2M |
| IPO Year | 2017 | 2014 |
| Metric | MYSZ | SCNI |
|---|---|---|
| Price | $0.52 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.3K | ★ 7.3M |
| Earning Date | 04-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.40 | 50.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,000.00 | N/A |
| Revenue This Year | $41.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 125.40 | N/A |
| 52 Week Low | $0.50 | $0.45 |
| 52 Week High | $1.65 | $6.18 |
| Indicator | MYSZ | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 32.69 | 45.03 |
| Support Level | N/A | $0.45 |
| Resistance Level | $0.68 | $0.71 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 8.60 | 14.78 |
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.